World Solve

Future progress on human development and planetary health depends on solving animal antibiotics entering food. Conventional approaches have proven insufficient. The required intervention must integrate community knowledge, data and appropriate technology while remaining affordable, privacy-preserving and operable with minimal external support. Strong solutions will articulate measurable impact metrics, risk mitigation strategies, and a plan for sustained operation by local actors after the pilot phase.

overuse of antibiotics continuing remains one of the most urgent challenges of our time. Systems currently in place are inadequate for the scale and complexity of the problem. A successful approach must work where resources are scarcest and demonstrate clear, measurable results. It should identify possible harms, respect local agency, and show how the solution can be maintained and expanded by the communities it is meant to serve.

Future progress on human development and planetary health depends on solving new antibiotics remaining few. Conventional approaches have proven insufficient. The required intervention must integrate community knowledge, data and appropriate technology while remaining affordable, privacy-preserving and operable with minimal external support. Strong solutions will articulate measurable impact metrics, risk mitigation strategies, and a plan for sustained operation by local actors after the pilot phase.

antibiotic resistance growing remains one of the most urgent challenges of our time. Systems currently in place are inadequate for the scale and complexity of the problem. A successful approach must work where resources are scarcest and demonstrate clear, measurable results. It should identify possible harms, respect local agency, and show how the solution can be maintained and expanded by the communities it is meant to serve.

Over the next two decades, rising resistance in bacteria, fungi, and parasites risks undermining surgery, chemotherapy, and intensive care. Global surveillance networks, rapid diagnostics, and new antimicrobial development platforms are crucial to avert a post-antibiotic era.

Resistance genes move through soil, water, and food chains, making hospital-focused interventions insufficient. One-Health regulatory frameworks and monitoring tools are required.

Overuse of antibiotics in health and agriculture breeds resistant pathogens. Stewardship programs and rapid diagnostics can reduce misuse.

Unregulated over-the-counter antibiotic sales and heavy use in livestock farming are breeding drug-resistant bacteria. Point-of-care rapid diagnostics could reduce unnecessary prescriptions.

Weak regulatory enforcement lets fake antimalarials and antibiotics reach patients, worsening drug resistance and deaths. Blockchain-based drug verification and stronger customs screening are promising solutions.

In major agricultural and industrial manufacturing regions across East and South Asia, overuse of antibiotics in livestock and unmonitored factory discharge have accelerated the proliferation of drug-resistant pathogens, threatening global healthcare systems.

Poor supply chain oversight allows fake antibiotics, malaria medications, and life-saving drugs to enter rural retail markets, leading to treatment failures and drug resistance.

Extended antibiotic use can disrupt gut bacteria in ways that cause lasting digestive problems for some patients, even after the antibiotics are no longer needed. Better protection of the gut microbiome during necessary antibiotic treatment remains undeveloped.

Some patients with chronic sinusitis continue experiencing symptoms even after surgical intervention, suggesting current treatments don't address every underlying cause. A more complete understanding and treatment approach remains needed.

Some patients continue experiencing symptoms long after completing standard treatment for Lyme disease, and doctors disagree on both the cause and the best way to treat this lingering illness. Resolving this uncertainty remains a significant unmet need.

This gut infection frequently returns after treatment, partly because antibiotics disrupt the broader gut microbiome that would normally help prevent it. Better prevention of recurrence remains an unresolved clinical challenge.

Bacteria evolve resistance faster than new antibiotics are being developed and approved, creating a widening treatment gap. Without new approaches, once-treatable infections could become far deadlier again.

Antibiotics are widely used in livestock farming to prevent disease and promote growth, contributing significantly to antibiotic resistance in humans. Reducing this use without harming farmers' livelihoods remains a persistent unresolved challenge.

Bacteria are evolving resistance faster than pharmaceutical companies are creating new antibiotics to fight them. Left unresolved, common infections could become deadly again within a few decades.

A persistent gap exists in realizing practical, scalable solutions for antibiotic-free recirculating aquaculture with zero nutrient discharge. Scientific understanding, engineering readiness and institutional capacity remain insufficient to translate promising concepts into durable impact under real-world constraints of cost, skills and governance.

A persistent gap exists in realizing practical, scalable solutions for microbiome restoration after repeated antibiotic exposure in children. Scientific understanding, engineering readiness and institutional capacity remain insufficient to translate promising concepts into durable impact under real-world constraints of cost, skills and governance.